These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19519550)

  • 1. Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
    Antonopoulos AS; Antoniades C; Tousoulis D; Bakogiannis C; Demosthenous M; Psarros C; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):76-87. PubMed ID: 19519550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting redox signaling in the vascular wall: from basic science to clinical practice.
    Antoniades C; Antonopoulos AS; Bendall JK; Channon KM
    Curr Pharm Des; 2009; 15(3):329-42. PubMed ID: 19149622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering.
    Margaritis M; Channon KM; Antoniades C
    Antioxid Redox Signal; 2014 Mar; 20(8):1198-215. PubMed ID: 24111702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of endothelial function: targets for nutritional and pharmacological interventions.
    Sudano I; Spieker LE; Hermann F; Flammer A; Corti R; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 2006; 47 Suppl 2():S136-50; discussion S172-6. PubMed ID: 16794451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.
    Gielis JF; Lin JY; Wingler K; Van Schil PE; Schmidt HH; Moens AL
    Free Radic Biol Med; 2011 Apr; 50(7):765-76. PubMed ID: 21172428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrobiopterin: a vascular redox target to improve endothelial function.
    Channon KM
    Curr Vasc Pharmacol; 2012 Nov; 10(6):705-8. PubMed ID: 23259560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction: potential clinical implications.
    Tousoulis D; Koutsogiannis M; Papageorgiou N; Siasos G; Antoniades C; Tsiamis E; Stefanadis C
    Minerva Med; 2010 Aug; 101(4):271-84. PubMed ID: 21030938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facing up the ROS labyrinth--Where to go?
    Rojas A; Figueroa H; Morales MA; Re L
    Curr Vasc Pharmacol; 2006 Jul; 4(3):277-89. PubMed ID: 16842145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Rap1 disrupts redox balance and impairs endothelium-dependent relaxations.
    Wong KHK; Cai Y; Ying F; Chen X; Vanhoutte PM; Tang EHC
    J Mol Cell Cardiol; 2018 Feb; 115():1-9. PubMed ID: 29277598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.
    Tousoulis D; Simopoulou C; Papageorgiou N; Oikonomou E; Hatzis G; Siasos G; Tsiamis E; Stefanadis C
    Pharmacol Ther; 2014 Dec; 144(3):253-67. PubMed ID: 24928320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and endothelial dysfunction: therapeutic implications.
    Gori T; Münzel T
    Ann Med; 2011 Jun; 43(4):259-72. PubMed ID: 21284528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of angiotensin receptor blocker with statin or thiazolidinediones as promising therapeutic strategy for metabolic syndrome and atherosclerosis.
    Kim-Mitsuyama S
    Hypertens Res; 2009 Aug; 32(8):639-40. PubMed ID: 19543234
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular protection in brain ischemia.
    Rodríguez-Yáñez M; Castellanos M; Blanco M; Mosquera E; Castillo J
    Cerebrovasc Dis; 2006; 21 Suppl 2():21-9. PubMed ID: 16651811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.
    Ceriello A
    Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitrous oxide and atherosclerosis. Pharmacotherapy of atherosclerosis and nitrous oxide].
    Markov KhM
    Kardiologiia; 2010; 50(12):69-77. PubMed ID: 21591396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.